+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Role of IκB kinase-β in the growth-promoting effects of angiotensin II in vitro and in vivo

Role of IκB kinase-β in the growth-promoting effects of angiotensin II in vitro and in vivo

Arteriosclerosis, Thrombosis, and Vascular Biology 33(12): 2850-2857

Angiotensin II (Ang II) is implicated in processes underlying the development of arterial wall remodeling events, including cellular hypertrophy and inflammation. We previously documented the activation of IκB kinase-β (IKKβ) in Ang II-treated cells, a kinase involved in inflammatory reactions. In light of a study suggesting a role of IKKβ in angiogenesis through its effect on the tuberous sclerosis (TSC)1/2-mammalian target of rapamycin complex 1 pathway in cancer cells, we hypothesized that targeting IKKβ could reduce arterial remodeling events by affecting both the inflammatory and the growth-promoting response of Ang II. Treatment of aortic vascular smooth muscle cells with Ang II induced the rapid and sustained phosphorylation of TSC1 on Ser511, which paralleled the activation of effectors of the mammalian target of rapamycin complex 1 pathway. Furthermore, we show that Ser511 of TSC1 acted as a phosphoacceptor site for Ang II-activated IKKβ. Consistent with this, the use of different short hairpin RNA constructs targeting IKKβ reduced Ang II-induced TSC1, S6 kinase, and eukaryotic translation initiation factor 4E-binding protein 1 phosphorylation and the rate of protein synthesis. Overexpression of TSC1 lacking Ser511 in vascular smooth muscle cells also exerted detrimental effects on the hypertrophic effect of Ang II. Furthermore, the selective IKKβ inhibitor N-(6-chloro-7-methoxy-9H-β-carbolin-8-yl)-2 methylnicotinamide reduced the inflammatory response and dose-dependently diminished Ang II-induced TSC1 phosphorylation and effectors of the mammalian target of rapamycin complex 1 pathway, leading to inhibition of protein synthesis in vitro and in rat arteries in vivo. Our findings provide new insights into the molecular understanding of the pathological role of Ang II and assist in identifying the beneficial effects of IKKβ inhibition for the treatment of cardiovascular diseases.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 055598444

Download citation: RISBibTeXText

PMID: 24135021

DOI: 10.1161/ATVBAHA.113.302487

Related references

Angiotensin-(1-7) has a dual role on growth-promoting signalling pathways in rat heart in vivo by stimulating STAT3 and STAT5a/b phosphorylation and inhibiting angiotensin II-stimulated ERK1/2 and Rho kinase activity. Experimental Physiology 93(5): 570-578, 2008

Opposite effects of nanocrystalline fullerene (C(60)) on tumour cell growth in vitro and in vivo and a possible role of immunosupression in the cancer-promoting activity of C(60). Biomaterials 30(36): 6940-6946, 2010

Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells. Molecular Pharmacology 48(4): 582-592, 1995

Role of nerve growth factor and its receptors in non-nervous cancer growth: efficacy of a tyrosine kinase inhibitor (AG879) and neutralizing antibodies antityrosine kinase receptor A and antinerve growth factor: an in-vitro and in-vivo study. Anti-Cancer Drugs 17(8): 929-941, 2006

Effects of angiotensin II type 2 receptor overexpression on the growth of hepatocellular carcinoma cells in vitro and in vivo. Plos One 8(12): E83754-E83754, 2014

Cushing's disease and hypertension: in vivo and in vitro study of the role of the renin-angiotensin-aldosterone system and effects of medical therapy. European Journal of Endocrinology 170(2): 181-191, 2014

Effects of biologically active tumor promoting and non promoting phorbol esters on in vitro growth of melanocytic cells. Pigment Cell Research 3(2): 98-100, 1990

The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo. Molecular Cancer Therapeutics 1(2): 85-94, 2002

Effects of heparin treatments in vivo and in vitro on adrenal angiotensin II receptors and angiotensin II-induced aldosterone production in rats. Acta Endocrinologica 119(3): 367-372, 1988

Growth promoting effects of angiotensin ii in the cardiovascular system. Maggi, M And V Geenen (Ed ) Serono Symposia Publications From Raven Press, Vol 76 Horizons in Endocrinology, Vol Ii; Second International Meeting Of Endocrinology Under 35, Siena, Italy, October 8-10, 1990 Xx+360p Raven Press: New York, New York, Usa Illus 265-272, 1991

Effects of angiotensin ii and of an angiotensin ii receptor antagonist on sv 40 induced tumor growth in vivo. Experientia (Basel) 36(4): 452-454, 1980

Adrenomedullin as a novel growth-promoting factor for cultured vascular smooth muscle cells: role of tyrosine kinase-mediated mitogen-activated protein kinase activation. Endocrinology 139(8): 3432-3441, 1998

Growth hormone exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymidine. Blood 80(6): 1443-1447, 1992

Effects of angiotensin II and of an angiotensin II receptor antagonist on simian virus 40-induced tumor growth in vivo. Experientia 36(4): 452-454, 1980